Irv Weissman

June 12, 2024

Dr. Weissman is a Professor of Clinical Investigation in Cancer Research and Professor of Developmental Biology at the Stanford School of Medicine, and previously served as the Director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine. As the first scientist to identify and isolate mammalian blood-forming stem cells in mice, Dr. Weissman is considered the father of hematopoiesis, and is an expert in stem cell biology, cancer stem cells, and macrophage immune checkpoints. Dr. Weissman’s lab was also the first to identify, prospectively isolate, and transplant human and murine HSCs. Dr. Weissman has helped found multiple companies, including Forty Seven Inc., which was acquired by Gilead Sciences in March 2020.